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Abstract
Background: Biocides are crucial to the prevention of infection by bacteria, particularly with the global emergence of
multiply antibiotic resistant strains of many species. Concern has been raised regarding the potential for biocide exposure
to select for antibiotic resistance due to common mechanisms of resistance, notably efflux.
Methodology/Principal Findings: Salmonella enterica serovar Typhimurium was challenged with 4 biocides of differing
modes of action at both low and recommended-use concentration. Flow cytometry was used to investigate the
physiological state of the cells after biocide challenge. After 5 hours exposure to biocide, live cells were sorted by FACS and
recovered. Cells recovered after an exposure to low concentrations of biocide had antibiotic resistance profiles similar to
wild-type cells. Live cells were recovered after exposure to two of the biocides at in-use concentration for 5 hours. These
cells were multi-drug resistant and accumulation assays demonstrated an efflux phenotype of these mutants. Gene
expression analysis showed that the AcrEF multidrug efflux pump was de-repressed in mutants isolated from high-levels of
biocide.
Conclusions/Significance: These data show that a single exposure to the working concentration of certain biocides can
select for mutant Salmonella with efflux mediated multidrug resistance and that flow cytometry is a sensitive tool for
identifying biocide tolerant mutants. The propensity for biocides to select for MDR mutants varies and this should be a
consideration when designing new biocidal formulations.
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Introduction
Salmonella enterica serovar Typhimurium is a major cause of
gastrointestinal disease and, as with many bacteria, Salmonella
infections are becoming harder to treat because a high percentage
of isolates are now resistant to commonly used antibiotics. Due to
this increasing prevalence of resistance in pathogenic isolates there
is a greater than ever requirement for effective cleaning and
disinfection regimes to prevent infections and contain outbreaks.
These regimes rely on the effective use of biocides, there is concern
that the resulting increased use of biocides in farming, food
production, hospital settings and the home is contributing to the
selection of antibiotic resistant strains as some mechanisms of
biocide resistance also confer antibiotic resistance [1]. Biocides
incorporate disinfectants, antiseptics and preservatives, com-
pounds that are often composed of a mixture of ingredients that
act upon a wide range of cellular mechanisms and targets. This
wide target base makes it difficult for bacteria to become resistant
to biocides [1]. However, biocides are not always used at the
correct concentration and can become compromised by coming
into contact with organic material [1]. Bacteria that survive a low
level dose of biocide are more likely to be resistant to antibiotics
[2]. A single exposure to some biocides has previously been found
to be insufficient to select for multidrug resistant (MDR) strains
[3], however, repeated, sub-inhibitory exposure to biocides does
result in selection of MDR bacteria. The increased accumulation
of biocides in the environment at low levels has the potential to
provide environments which will favour the selection of mutants
with increased tolerance to biocides and antibiotics [4].
Low-level biocide-antibiotic cross resistance can result from the
increased expression of efflux pumps, particularly in Enterobac-
teriaceae the tri-partite AcrAB-TolC system [5,6]. AcrAB-TolC is
the major multidrug efflux pump in many Gram-negative bacteria,
including Salmonella, and has been shown to be over-expressed in
Salmonella in response to exposure to low doses of biocide [3,7].
Non-specific, low-level resistance to antibiotics and biocides can
also be mediated by decreasing permeability of the membrane
often due to repression of major porins [8]. As well as its role in
antimicrobial resistance, the AcrAB-TolC efflux pump also has a
role in Salmonella pathogenicity, all three of the components being
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22833required for virulence [9,10,11]. Salmonella, as with all bacteria, has
a large complement of transporters with nine known multidrug
efflux systems [12]. Whilst AcrAB is the major system, expression
of other RND pumps (AcrEF and AcrD) is co-ordinately regulated
with AcrAB in Salmonella and AcrEF can functionally complement
AcrAB [13]. AcrAB-TolC production is tightly regulated, three
homologous global activators, MarA, SoxS and Rob, and one
local repressor, AcrR, have been shown to regulate acrAB in
Escherichia coli [14,15,16,17,18]. An additional activator, RamA,
also homologous to MarA, SoxS and Rob, is involved in acrAB
regulation in Salmonella but is absent in E. coli [19]. Over-
expression of RamA leads to an increase in expression of both
acrAB and acrEF [20,21].
Flow cytometry (FCM) and fluorescence-activated cell sorting
(FACS) are techniques that can investigate and separate individual
bacteria from large populations depending on their light scattering
and fluorescent properties. Fluorescent dyes can be used to
monitor membrane integrity and potential and thus monitor
bacterial physiology; a major advantage of the technique is that it
does not rely upon bacterial growth on agar plates or in broth, and
so is suitable for studying bacteria having a viable but non-
culturable (VNC) phenotype. In this study we have utilised FCM
to analyse the physiological response of the model food borne
pathogen Salmonella to both low-level and ‘‘in-use’’ concentrations
of biocides. Using FACS we isolated mutants able to survive
challenge with ‘‘in-use’’ concentrations of two biocides after one
exposure. These mutants were multidrug resistant and over-
expressed the AcrEF efflux pump and MarA, demonstrating that
biocide exposure can select for mutants with a broad, low-level
antibiotic resistance.
Results
Inhibitory concentrations of biocides
The recommended in-use concentration for all the biocides
tested is 1%, Virkon (V), an oxidative compound, was found to
inhibit growth of Salmonella at 0.25% (v/v), Superkill (SK), a
mixture of aldehydes and quaternary ammonium compounds
(QACs) at 0.002%, AQAS (AQ), a quaternary ammonium
compound, at 0.002% and Trigene (TR), a halogenated tertiary
amine compound, at 0.0005%.
Isolation of viable cells from low and in-use
concentrations of biocide
Exposure to biocide concentrations of 0.4% (V), 0.005% (SK),
0.005% (AQ) and 0.002% (TR) were used to provoke a ‘‘low’’ dose
challenge of each biocide, where bacterial growth was inhibited
but bacteria were not necessarily killed. Each biocide was also
tested at the recommended working concentration of 1%, after
5 hours incubation in biocide each culture was analysed using
FCM and PIX staining (Figure 1). After low dose challenge, the
biocides generated different physiological effects as revealed by
FCM. The majority of cells in Superkill or Trigene were in the
lower left (‘‘healthy’’) quadrant, 74% and 60% respectively, the
majority of the remaining cells being in the upper left quadrant
(disrupted membrane potential but not ruptured membrane). The
biocide AQAS had a greater antimicrobial effect and only 39% of
cells remained in the ‘‘healthy’’ quadrant. Virkon had a much
more pronounced effect with only 0.3% of cells in the ‘‘healthy’’
quadrant after a low dose exposure, the majority of cells in the
upper right ‘‘dead’’ quadrant. The healthiest cells in each
population were sorted by FACS (Figure 1a), each sorted
population gave rise to viable colonies on LB agar which were
retained for further investigation.
After an ‘‘in-use’’ dose challenge the majority of cells were in the
upper right ‘‘dead’’ quadrant (V 98%, SK 88%, AQ 98%, TR
70%) (figure 1b). These cells were stained by both PI and BOX,
therefore had ruptured membranes, no membrane potential and
were presumed dead. Surprisingly there were cells in each biocide
not stained by PI or BOX, maintaining an intact membrane/
membrane potential, present at a low frequency. These popula-
tions (circled) were sorted, cells sorted from Virkon and AQAS
gave no culturable colonies but cells sorted after high-level
Superkill and Trigene treatment were recovered and representa-
tives retained (referred to as SK 1% and TR 1%).
Colonies isolated from in-use concentrations of biocide
have reduced susceptibility to multiple antibiotics but
not to biocides
The colonies isolated from the low dose of biocide had an
antibiotic susceptibility profile identical to SL1344. The two
mutants isolated from in-use concentrations of Superkill and
Trigene had a broad, low-level reduced susceptibility to multiple
antibiotics, nalidixic acid (4- fold), chloramphenicol (3-fold),
tetracycline (2-fold), and ciprofloxacin (2-fold) (Table 1). They
also had a 2-fold reduced susceptibility to the biocide triclosan.
Populations of healthy cells recovered after exposure to a low
dose of biocide were challenged again with the same level of
biocide and re-analysed by FCM. The percentage of cells present
in the lower-left ‘‘healthy’’ quadrant was not significantly different
to that of SL1344 when first challenged. This suggests that the
potential to survive exposure to a low dose of biocide is randomly
distributed amongst a population, reflecting heterogeneity in terms
of growth phase and/or gene expression amongst the population;
cells able to survive a single exposure to a low biocide concen-
tration were not pre-disposed to biocide survival upon repeat
challenge. The mutants recovered from the in-use biocide
challenge were however stably multidrug resistant although they
showed no increase in MIC of the biocide from which they were
recovered.
Biocides have varying effects on cell growth rate
Cells sorted from low dose challenge with Virkon and Trigene
grew at a similar rate to wild-type cells in broth when no biocide
was added (Figure 2a). Cells sorted from low dose challenge with
Superkill had a slightly longer lag phase than wild-type cells and
cells sorted from AQAS did not achieve as high an optical density
after the same length of time. The mutants sorted from in-use
concentrations of Superkill and Trigene had a longer lag phase
than SL1344 and only achieved a final OD600 of 0.9, significantly
lower than the OD600 of 1.5 achieved by SL1344 after 16 hours
growth (Figure 2b). This shows a fitness cost has been incurred by
both mutants.
Cells isolated from in-use concentrations of biocide have
increased efflux activity
The efflux activity of the sorted cells was assessed by measuring
intracellular accumulation of Hoescht 33342, a known substrate of
MDR efflux pumps. The cells exposed to a low-dose of biocide
accumulated levels of Hoescht dye similar to SL1344 (data not
shown). The two mutants recovered from the in-use biocide
challenge both accumulated significantly less dye than SL1344
(Figure 3) and in the presence of an efflux pump inhibitor PAßN,
accumulation of Hoescht was elevated, confirming that these
mutants have increased efflux activity compared with SL1344
(Figure 3).
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mutants
Comparative RT-PCR was used to determine the level of
expression of genes relevant to multidrug resistance in the high-
level biocide mutants. In both mutants the expression of ompF, soxS
and acrB was statistically significantly down-regulated in compar-
ison with SL1344 (Figure 4). The ramA gene was significantly
down-regulated in SK 1% but not TR 1%. The down-regulation
of acrB in both mutants was a surprise as this is usually considered
the major efflux system in Salmonella. In both SK 1% and TR 1%,
marA (2 fold) and acrF (10 fold and 7 fold respectively) expression
was however significantly increased compared to SL1344 (Figure 4)
indicating that the efflux pump AcrEF-TolC is mediating the
MDR phenotype in these mutants. Sequencing showed up-
regulation of MarA was not due to a mutation in the marA
promoter or within marR.
To confirm that AcrEF over-expression was responsible for the
MDR phenotype seen in these mutants, we inactivated acrEF in
these strains, this resulted in a broad loss of MDR (Table 1) thus
Table 1. Susceptibility of biocide tolerant mutants to
antibiotics.
MIC (mg/ml)
Nal Chl Tet Kan Tric Cip
SL1344 2 1 0.5 4 0.06 ,0.015
SK 1% 32 8 2 4 0.25 0.06
TR 1% 32 8 2 8 0.12 0.06
SK 1% acrEF::cat 8 N/A 0.5 4 0.12 ,0.015
TR 1% acrEF::cat 8 N/A 0.5 4 0.12 ,0.015
Nal=nalidixic acid, Chl=chloramphenicol, Tet=tetracycline, Kan=kanamycin,
Tric=triclosan, Cip=ciprofloxacin.
doi:10.1371/journal.pone.0022833.t001
Figure 1. Analysis of the impact of biocide exposure on a population. Flow cytometry analysis of 10,000 S. Typhimurium cells after 5 hours
challenge with a) low dose (SK 0.005%, AQ 0.005%, TR 0.002% and V 0.4%) and b) in-use concentration (1%) of 4 different categories of biocide. For
each plot, the x-axis plots PI fluorescence and the y-axis BOX fluorescence. Quadrants represent: lower left, PI
2 BOX
2 therefore ‘healthy’; upper left,
PI
2 BOX
+ therefore intact but depleted membrane potential (‘unhealthy’); upper right, PI
+ BOX
+ therefore disrupted membrane and membrane
potential and likely to be dead. The circles indicate cells sorted for further investigation.
doi:10.1371/journal.pone.0022833.g001
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biocide concentration. The cells selected from Superkill show a slightly increased lag phase but grow to the same final OD600 as the WT. Lines show a
mean of 3 technical replicates and are representative of the cells isolated from each biocide. Error bars are standard deviations of the technical
replicates. SL1344 is shown by a continuous line, Superkill by a circle, AQAS by a triangle, Virkon by a square and Trigene by a cross. Panel B. Growth
kinetics of SL1344 and mutants sorted from high-level biocide concentrations. The mutants have a much longer lag phase and fail to reach the same
final OD600 as the WT. Lines show a mean of 3 biological replicates with the standard deviation. SL1344 is shown by a continuous line, SK 1% by a
circle and TR 1% by a square.
doi:10.1371/journal.pone.0022833.g002
Biocides Select MDR Salmonella
PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22833confirming that the AcrEF pump is integral to the MDR
phenotype seen. As acrEF has been reported to be regulated by
FNR in E. coli [26] we investigated the level of fnr expression in our
mutants but the level of expression was not significantly different
between the mutants and wild-type.
Effect of acrB, tolC and ramR mutations on SL1344
survival in low dose biocide
To further explore the role of efflux in biocide tolerance a series
of isogenic mutants (table 2) lacking components of AcrAB-TolC
or over-expressing this system were examined for their ability to
survive biocide exposure. The AcrAB-TolC system was studied as
this is constitutively expressed whereas AcrEF is cryptic in wild-
type cells. After 5 hours incubation in low dose biocide, the
physiology of the wild-type strain SL1344 and isogenic mutants
lacking a functional acrB, tolC and ramR were assessed by FCM
(Figure 5). The striking result was that the ramR mutant (which
over-expresses AcrAB-TolC) had a significantly greater proportion
of cells in the lower-left ‘‘healthy’’ quadrant than SL1344 for all 4
of the biocides tested. The biggest effects were seen with Superkill
and AQAS where percentages in the lower-left ‘‘healthy’’
quadrant for SL1344 were 5% and 36% respectively whereas
for the ramR mutant 98% of cells in each biocide were in this
quadrant. In each case, the wild-type had a larger proportion of
BOX+ bacteria, lacking membrane potential, than the ramR
mutant. A smaller but still consistent effect was seen for the
Trigene and Virkon biocides where the ramR mutant had higher
‘‘healthy’’ percentages, 99% compared to 95% in Trigene and
1.8% to 0.2% in Virkon, where the majority of the remaining
bacteria were in the upper-right ‘‘dead’’ quadrant. Virkon in
particular seemed not to be affected by efflux pump loss or over-
expression; this was also suggested by the addition of the efflux
pump inhibitor (EPI) PAbN, which decreased the percentage of
cells of SL1344 in the lower-left quadrant for all biocides bar
Virkon (Figure 5).
Discussion
Successful prevention and eradication of outbreaks of bacterial
infection relies on biocide use, as a result biocides must be able to
rapidly and completely kill large populations of bacteria.
Previously we have shown that repeated exposure of Salmonella
to low levels of biocide can select for multidrug resistant mutants,
in our previous work we were unable using conventional culture
based techniques to isolate mutants with increased biocide
tolerance. In this study we show that FCM is a very useful
technique for identifying populations of bacteria that can
withstand biocide challenge; FACS has the added advantage of
allowing the physical isolation of those biocide-resistant bacteria
for further investigation. The fact that FACS succeeded in
isolating resistant mutants where plate-based screening failed
suggests that the FACS method aids bacterial survival in this
context; possibly as a result of the decoupling of the selection and
growth processes.
Using this approach we were able to show that a single, low-
level exposure to 2–4X the MIC of biocide, whilst preventing
growth in broth did not rupture the membranes of a large
proportion of a population (with the exception of Virkon) and that
sorted ‘healthy’ cells were not MDR. This supports the previous
findings that more than one exposure to a low level of biocide is
required to select antibiotic resistant mutants. This might reflect
the fact that most cells can survive this low-level stress (even if not
able to grow) and that the natural variation within a population
includes cells relatively unaffected by low-level biocide exposure.
Therefore there is little pressure for selection of mutants with
increased resistance. The flow cytometer was however also able to
identify and recover mutants from populations that had been
exposed to an extreme 1% biocide challenge. Subsequent,
replicate experiments with traditional culture methods did not
recover live mutants after incubation with 1% biocide. This
indicates the potential for FACS to identify and select mutants that
occur at a very low frequency.
Figure 3. Efflux activity of biocide selected mutants. Relative levels of Hoescht accumulation by SL1344 and mutants recovered from high-
level biocide exposure in the absence (white) and presence (black) of PAbN. Experiments were performed in triplicate, and the error bars indicate
standard deviations. An asterisk indicates a statistically significant difference compared to the wild-type (P,0.05).
doi:10.1371/journal.pone.0022833.g003
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viable bacterial numbers; in our experiments the proportion of
cells in a population that were able to maintain a membrane
potential after 5 hours exposure to the working concentration of
biocide was 2% in Virkon and AQAS, 12% in Superkill and 30%
in Trigene. After sorting, the vast majority of these populations did
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Figure 4. Expression of genes associated with multidrug resistance. Relative levels of gene expression by SL1344 and mutants recovered
from high-level biocide exposure after growth to mid-logarithmic phase in LB broth. The data show the mean of 4 biological replicates and 2
technical replicates for each gene. Standard deviation and students ‘t’-test were used to validate the data and any significant difference in the
mutants compared to SL1344 (P,0.05) is indicated by an asterisk.
doi:10.1371/journal.pone.0022833.g004
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and Trigene. However, we made no efforts to improve this
recovery rate with the addition of a richer recovery medium than
LB. The isolation of some immediately viable cells from a larger
population of cells that maintain a membrane potential might
suggest this population is highly heterogeneous and comprises
efflux mutants as characterised here and possibly a larger viable
but non-culturable population. Further work to investigate this is
warranted.
The two resistant mutants characterised had a classic, low-level
MDR phenotype with a slightly increased resistance to a broad
range of drugs from different classes of antibiotics. The AcrAB-
TolC efflux pump has been shown to be the most important efflux
pump in expelling antibiotics from Salmonella. It was therefore
expected that expression of this pump would be up-regulated in
our recovered cells. However, the down regulation of acrB and the
up-regulation of acrF indicate that the AcrEF-TolC efflux pump is
the main driver in the MDR phenotype of these two mutants. This
was confirmed by inactivation of AcrEF-TolC in these strains.
Previous work has indicated a relationship between AcrAB-TolC
and AcrEF-TolC; over-expression of AcrEF-TolC can comple-
ment AcrB deletion [13]. The fact that both the mutants recovered
from two different biocides had this phenotype suggests a common
mechanism of cell survival to biocides with de-repression of AcrEF
(mediated by up-regulation of MarA) favoured over de-repression
of AcrAB. The MarA regulon has not been shown to include acrEF
in Salmonella; however in E. coli a putative MarA binding site in the
acrEF promoter has been described [22]. Study of the S.
Typhimurium acrEF promoter region confirms that this putative
MarA binding site is also present and is a better match, by 1 base,
to the putative binding site consensus sequence. This suggests that
AcrEF de-repression in the mutants is a result of MarA over-
expression. Sequencing of the mutant’s marA promoter region
showed no mutations. The genetic basis for marA de-repression in
the mutants studied here is therefore currently unknown.
Of the isogenic mutants tested for ability to survive a low dose of
biocide, only a ramR mutant had a discernable effect on the
survival of the cells. This mutant is MDR and over-expresses
AcrAB-TolC [23]. This suggests therefore that AcrAB-TolC can
recognise some biocides as substrates (excluding Virkon) and that
de-repression of AcrAB-TolC will be protective against biocide
stress. Surprisingly, loss of acrB or tolC did not have a very
Table 2. Strains used in this study.
Strain Description Origin/reference
SL1344 Wild-type [24]
L109 SL1344, tolC::aph [9]
L110 SL1344, acrB::aph [9]
L1007 SL1344, ramR::aph [27]
SK1 Mutant of SL1344 derived
after superkill treatment
This study
TR1 Mutant of SL1344 derived
after trigene treatment
This study
EG16568 SL1344, acrEF::cat [28]
SK1-acrEF SK1, acrEF::cat This study
TR1-acrEF TR1, acrEF::cat This study
doi:10.1371/journal.pone.0022833.t002
Figure 5. Impact of efflux on biocide survival. Flow cytometry analysis of the physiological state of 10,000 cells of SL1344, acrB, tolC and ramR
isogenic mutants after a 5 hour exposure to a low dose of four different biocides. The final column shows the effect of addition of PAbN (100 mg/ml)
on SL1344. The x-axis plots PI fluorescence and the y-axis BOX fluorescence.
doi:10.1371/journal.pone.0022833.g005
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systems can complement the loss of the AcrAB-TolC pump.
Chemical inactivation of efflux with PAbN also decreased the
survival of the cells in Superkill, AQAS and Trigene. This again
suggests that efflux is an intrinsic mechanism by which biocides are
expelled from the cell; once again cells grown in Virkon were less
affected by the addition of PAbN; more evidence efflux is of little
importance in the elimination of this biocide.
This study has shown that Salmonella can survive challenge with
in-use concentrations of some biocides, that this is due to de-
repression of the AcrEF MDR efflux system and that these
mutants are MDR. Flow cytometry is a sensitive tool for
evaluating the cidal potential of biocides which offers significant
advantages over culture based methods. Our work suggests the
potential for different biocides to select for MDR varies; the
development of novel biocide formulations should bear this in
mind.
Materials and Methods
Isolation of biocide tolerant mutants
Salmonella enterica serovar Typhimurium strain SL1344 [24] was
the parent strain used in all experiments, for biocide exposure
overnight cultures (5 ml) of SL1344 were grown in LB broth at
37uC and used to inoculate fresh 5 ml LB broths containing the
desired concentration of different biocides. After 5 hours samples
were removed and analysed by FCM. An ethanol killed sample of
bacteria was used as a control. For each experiment 10,000 cells
were analysed and fluorescence from two dyes, PI (stains the DNA
of bacteria that have lost membrane integrity) and BOX (stains
bacteria with a collapsed membrane potential) used to identify cells
with maintaining a membrane potential which were sorted by
FACS into FACSFlow buffer and aliquoted onto LB agar plates.
Colonies that grew were stored on Protect Beads (Technical
Service Consultants Ltd). Full details of the methodology are given
in Material S1.
Phenotypic characterisation of biocide tolerant mutants
Cells recovered after biocide exposure were characterised in
terms of their antimicrobial susceptibility using broth micro-
dilution and agar dilution methods following the recommenda-
tions of the British Society for Antimicrobial Chemotherapy [25].
The growth of sorted biocide tolerant mutants compared to the
parental strain SL1344 was also analysed measuring the optical
density at 600 nm of replicate cultures. Full details of the
methodology are given in Material S1.
The role of efflux
Efflux activity was determined phenotypically by measuring the
accumulation of Hoescht 33342, a substrate of MDR efflux
systems according to the method of Webber & Coldham [26].
Accumulation of Hoescht 33342 was measured in the presence
and absence of PAbN, an efflux pump inhibitor, added to a final
concentration of 100 mg.ml-1. Expression of efflux pump genes
acrB, acrEF, known regulators marA. soxS, ramA and fnr, porin ompF
and 16S rRNA (rrsH) was also determined using comparative RT-
PCR as previously described [13]. Primers and full details are
listed in Table S1. To confirm its role in multidrug resistance, the
acrEF locus was disrupted in the SK 1% and TR 1% mutants using
bacteriophage P22. Full details of the methodology are given in
Material S1.
Supporting Information
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(DOC)
Table S1 Primers used in this study.
(DOC)
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